Table 1 Characteristics of the 200 participants
From: Transcutaneous canine breast cancer detection in Tunisia: a pilot study
Variables | Overall (n = 200) | Breast cancer group (n = 100) | Control group (n = 100) |
|---|---|---|---|
Female, n(%) | 200 (100) | 100(50) | 100(50) |
Age, (years), median [interquartile range] | 51,82 [26; 81] | 53,47 [26;81] | 50,17[29;66] |
Menopausal, n (%) | 107(53) | 56(56) | 51(51) |
Most frequently reported past or current diseases | |||
 Hypertension,n (%) | 60(30) | 32(5) | 28 (28) |
 Diabetes, n (%) | 64(32) | 32(4) | 34 (34) |
 Dyslipidemia, n (%) | 60 (30) | 34(3) | 28 (28) |
 Mastopathy, n (%) |  | NA | 23 (23) |
Current treatments | |||
 Oral anti-diabetic, n (%) | 51(25) | 23 (23) | 28(19) |
 Insulin, n (%) | 29(14) | 16 (16) | 13(13) |
 Anti-hypertension, n (%) | 56(28) | 30(30) | 26 (26) |
 Anti-dyslipidemic, n (%) | 54(27) | 30 (30) | 24(24) |